Joanne Mortimer

18.0k total citations · 2 hit papers
260 papers, 9.5k citations indexed

About

Joanne Mortimer is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Joanne Mortimer has authored 260 papers receiving a total of 9.5k indexed citations (citations by other indexed papers that have themselves been cited), including 183 papers in Oncology, 77 papers in Pulmonary and Respiratory Medicine and 55 papers in Cancer Research. Recurrent topics in Joanne Mortimer's work include HER2/EGFR in Cancer Research (47 papers), Cancer Treatment and Pharmacology (45 papers) and Advanced Breast Cancer Therapies (35 papers). Joanne Mortimer is often cited by papers focused on HER2/EGFR in Cancer Research (47 papers), Cancer Treatment and Pharmacology (45 papers) and Advanced Breast Cancer Therapies (35 papers). Joanne Mortimer collaborates with scholars based in United States, Canada and Saudi Arabia. Joanne Mortimer's co-authors include Farrokh Dehdashti, Christina M. Dieli‐Conwright, Barry A. Siegel, John A. Katzenellenbogen, Kyuwan Lee, Walter Kocha, Norman Estes, David P. Kelsen, Daniel G. Haller and Jack A. Roth and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Joanne Mortimer

247 papers receiving 9.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chemotherapy Followed by Surgery Compared with Surgery Alone for Localized Esophageal Cancer

1998 997 citations Joanne Mortimer et al. profile →
A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck.

1992 465 citations Joanne Mortimer et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Joanne Mortimer

Since Specialization

Citations

This map shows the geographic impact of Joanne Mortimer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanne Mortimer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanne Mortimer more than expected).

Fields of papers citing papers by Joanne Mortimer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanne Mortimer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanne Mortimer. The network helps show where Joanne Mortimer may publish in the future.

Co-authorship network of co-authors of Joanne Mortimer

This figure shows the co-authorship network connecting the top 25 collaborators of Joanne Mortimer. A scholar is included among the top collaborators of Joanne Mortimer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanne Mortimer. Joanne Mortimer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Telehealth-Based Behavioral Intervention for Cancer-Related Cognitive Decline in Older Adults Undergoing Systemic Therapy for Breast Cancer: Development and Usability Testing 2025 ·JMIR Formative Research ·Joanna Kelly, (unknown), (unknown), (unknown), Valerie Targia, Jessica Bauer, Joanne Mortimer, (unknown), (unknown), (unknown), (unknown), (unknown), Supriya G. Mohile, Michelle C. Janelsins, Robert J. Ferguson, Alissa Huston, Allison Magnuson	0
2	Impact of neoadjuvant pembrolizumab adherence on pathologic complete response in triple-negative breast cancer: a real-world analysis 2024 ·The Oncologist ·(unknown), (unknown), (unknown), Nora Ruel, Heather L. McArthur, James Waisman, Joanne Mortimer	9
3	Breast cancer incidence and mortality by metabolic syndrome and obesity: The Women’s Health Initiative 2024 ·Cancer ·Rowan T. Chlebowski, Aaron K. Aragaki, Kathy Pan, Michael S. Simon, Marian L. Neuhouser, Reina Haque, Thomas E. Rohan, Jean Wactawski‐Wende, Tonya Orchard, Joanne Mortimer, Dorothy S. Lane, Andrew M. Kaunitz, Pinkal Desai, Robert A. Wild, Ana Barac, JoAnn E. Manson	15
4	Outcome prioritization and preferences among older adults with cancer starting chemotherapy in a randomized clinical trial 2024 ·Cancer ·Enrique Soto‐Pérez‐de‐Celis, William Dale, Vani Katheria, Heeyoung Kim, Marwan Fakih, Vincent Chung, Dean Lim, Joanne Mortimer, Leana Cabrera Chien, Kemeberly Charles, Elsa Roberts, Jessica Vázquez, Jeanine Moreno, Tak Yan Lee, Simone Fernandes Dos Santos Hughes, Mina S. Sedrak, Can‐Lan Sun, Daneng Li	13
5	A phase I/II trial of palbociclib, pembrolizumab, and endocrine therapy for patients with HR+/HER2- locally advanced or metastatic breast cancer (MBC): Clinical outcomes and stool microbial profiling. 2024 ·Journal of Clinical Oncology ·(unknown), Colt A. Egelston, Susan E. Yost, Paul Frankel, (unknown), Christopher Ruel, Daniel Schmolze, Peter P. Lee, Christina Yeon, Yuan Yuan, James Waisman, Sumanta K. Pal, Joanne Mortimer	1
6	Abstract PO4-20-10: Value of 16α-18F-fluoro-17β-fluoroestradiol PET imaging in ER-positive breast cancer: a case report 2024 ·Cancer Research ·(unknown), Veronica Jones, Dave Yamauchi, Joanne Mortimer	0
7	Smoking prevalence and association with sociodemographic variables in cancer clinical trial participants 2024 ·Cancer ·Cary A. Presant, Cathee Till, Riha Vaidya, Kimlin Ashing, Graham Warren, Virginia Sun, Ravi Salgia, Erminia Massarelli, Joanne Mortimer, Sumanta K. Pal, Tanya B. Dorff, Arya Amini, Loretta Erhunmwunsee, Tanyanika Phillips, Dawn L. Hershman, Joseph M. Unger	1
8	The Challenges of Treating Patients with Breast Cancer and Obesity 2023 ·Cancers ·(unknown), Joanne Mortimer	15
9	Summary: Appropriate Use Criteria for Estrogen Receptor–Targeted PET Imaging with 16α-¹⁸F-Fluoro-17β-Fluoroestradiol 2023 ·Journal of Nuclear Medicine ·Gary A. Ulaner, David A. Mankoff, Amy S. Clark, Amy M. Fowler, Hannah M. Linden, Lanell M. Peterson, Farrokh Dehdashti, Brenda F. Kurland, Joanne Mortimer, Jason Mouabbi, Dae Hyuk Moon, Elisabeth G.E. de Vries	46
10	Hyperglycemia and Glycemic Variability Associated with Glucocorticoids in Women without Pre-Existing Diabetes Undergoing Neoadjuvant or Adjuvant Taxane Chemotherapy for Early-Stage Breast Cancer 2023 ·Journal of Clinical Medicine ·(unknown), Sayeh Lavasani, (unknown), (unknown), Mina S. Sedrak, Daphne Stewart, James Waisman, Yuan Yuan, (unknown), Raynald Samoa, Nora Ruel, Susan E. Yost, (unknown), (unknown), Joanne Mortimer	0
11	Bilateral Oophorectomy and Colorectal Cancer Incidence and Mortality in the Women's Health Initiative 2023 ·Cancer Epidemiology Biomarkers & Prevention ·(unknown), Rebecca A. Nelson, Laura Kruper, Joanne Mortimer, Juhua Luo, Su Yon Jung, Robert B. Wallace, Rowan T. Chlebowski	1
12	HER2-targeted antibody–drug conjugates for breast cancer: ancestry and dose adjustment for thrombocytopenia 2023 ·Breast Cancer ·Michael Rainone, Carolyn E. Behrendt, Saro Kasparian, (unknown), Mina S. Sedrak, Sayeh Lavasani, Daphne Stewart, Yuan Yuan, Joanne Mortimer, James Waisman, Niki Patel, Vinod Pullarkat	3
13	Tumor-infiltrating exhausted CD8+ T cells dictate reduced survival in premenopausal estrogen receptor–positive breast cancer 2022 ·JCI Insight ·Colt A. Egelston, Weihua Guo, Jiayi Tan, Christian Avalos, Diana L. Simons, (unknown), Yinghui Huang, Michael S. Nelson, (unknown), Daniel Schmolze, John H. Yim, Laura Kruper, Laleh G. Melstrom, Kim Margolin, Joanne Mortimer, Yuan Yuan, James Waisman, Peter P. Lee	25
14	Use of HER2-Directed Therapy in Metastatic Breast Cancer and How Community Physicians Collaborate to Improve Care 2020 ·Journal of Clinical Medicine ·Joanne Mortimer, Laura Kruper, Mary Cianfrocca, Sayeh Lavasani, (unknown), (unknown), Mina S. Sedrak, (unknown), Daphne Stewart, James Waisman, Christina Yeon, Tina Wang, Yuan Yuan	3
15	Strategies to Improve Participation of Older Adults in Cancer Research 2020 ·Journal of Clinical Medicine ·Jennifer Liu, (unknown), (unknown), Simran Padam, Daneng Li, William Dale, Sumanta K. Pal, Daphne Stewart, (unknown), Linda D. Bosserman, Cary A. Presant, Tanyanika Phillips, (unknown), A. B. Hill, (unknown), Christina Yeon, Mary Cianfrocca, Yuan Yuan, Joanne Mortimer, Mina S. Sedrak	17
16	Effects of Aerobic and Resistance Exercise on Metabolic Syndrome, Sarcopenic Obesity, and Circulating Biomarkers in Overweight or Obese Survivors of Breast Cancer: A Randomized Controlled Trial 2018 ·Journal of Clinical Oncology ·Christina M. Dieli‐Conwright, Kerry S. Courneya, Wendy Demark‐Wahnefried, Nathalie Sami, Kyuwan Lee, Thomas A. Buchanan, Darcy Spicer, Debu Tripathy, Leslie Bernstein, Joanne Mortimer	271
17	Human breast tumor-infiltrating CD8+ T cells retain polyfunctionality despite PD-1 expression 2018 ·Nature Communications ·Colt A. Egelston, Christian Avalos, Travis Y. Tu, Diana L. Simons, (unknown), Jae Yoon Jung, Laleh G. Melstrom, Kim Margolin, John H. Yim, Laura Kruper, Joanne Mortimer, Peter P. Lee	97
18	Hispanic ethnicity as a moderator of the effects of aerobic and resistance exercise in survivors of breast cancer 2018 ·Cancer ·Christina M. Dieli‐Conwright, Frank C. Sweeney, Kerry S. Courneya, Debu Tripathy, Nathalie Sami, Kyuwan Lee, Thomas A. Buchanan, Darcy Spicer, Leslie Bernstein, Joanne Mortimer, Wendy Demark‐Wahnefried	18
19	Triple-negative breast cancer: Novel therapies and new directions 2009 ·Maturitas ·Sumanta K. Pal, Joanne Mortimer	43
20	Weekly herceptin with navelbine in chemonaïve patients with HER2 positive metastatic breast cancer: A phase II multicenter trial 2001 ·Breast Cancer Research and Treatment ·Mohammad Jahanzeb, Joanne Mortimer, F. Yunus, (unknown), (unknown), Alan J. Koletsky, Pamela Klein, (unknown), (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact